Home » Topics » BioWorld Science

BioWorld Science
RSS

Ichnos nominates ISB-1442 as its next clinical candidate

Aug. 9, 2021

ImmVira receives NMPA approval for clinical testing of intravenous MVR-T3011

Aug. 9, 2021

New SHP-2 inhibitors identified at Beijing Innocare Pharmaceutical Technology

Aug. 9, 2021

Dongguan Hec New Drug Research and Development, Sunshine Lake Pharma identify HBV inhibitors

Aug. 9, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent PROTACs targeting cereblon

Aug. 9, 2021

Heparegenix identifies new MAPKK 4 inhibitors

Aug. 9, 2021

Discovery and preclinical characterization of a novel anti-SARS-CoV-2 MAb, MW-06

Aug. 9, 2021

Enrollment ongoing in first-in-human study of [68Ga]-FF58

Aug. 6, 2021

GI Innovation begins patient enrollment in phase I/II study of GI-101

Aug. 6, 2021

Labile iron pool radiotracer [18F]TRX can predict sensitivity to iron-targeted tumor therapies

Aug. 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...